Close Menu

NEW YORK – Drug discovery firm Metrion Biosciences said Tuesday that it has closed on £2.7 million ($3.7 million) in new equity financing, including £2.25 million from lead investor Gresham House Ventures.

Cambridge, UK-based Metrion said it will use the funding to expand its laboratories, invest in specialty equipment, develop its cell line library, add GLP cardiac safety services, and expand its business to the US.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.